Biological Age Test Comparison: Which Epigenetic Clock Is Most Accurate?
Your passport says one thing. Your body might be saying something entirely different. Biological age — the measure of how old your cells and tissues actually function compared to your chronological age — has become one of the more fascinating frontiers in health science over the past decade. And if you’ve spent any time down the rabbit hole of longevity research, you’ve probably encountered the term epigenetic clock. But which one should you actually trust, and what does “accuracy” even mean in this context?
Related: science of longevity
As someone who teaches Earth Science at Seoul National University and manages a brain that runs on four parallel tracks simultaneously (thanks, ADHD), I’ve developed a genuine appreciation for tools that give you real, actionable data about your body. The explosion of commercial epigenetic tests has made this science accessible to regular people, not just researchers. But with that accessibility comes a lot of marketing noise. Let’s cut through it.
What Is an Epigenetic Clock, Really?
Before comparing clocks, you need a solid conceptual foundation. DNA methylation is the mechanism most epigenetic clocks rely on. As you age, specific cytosine bases in your DNA acquire or lose methyl groups in highly predictable patterns. These methylation patterns shift across hundreds to thousands of CpG sites — locations in the genome where a cytosine is followed by a guanine. The key insight, confirmed repeatedly in the literature, is that these patterns correlate remarkably well with chronological age and, more importantly, with health outcomes.
An epigenetic clock is essentially an algorithm trained on methylation data from large human cohorts. Feed it your methylation profile, and it spits out an age estimate. Simple in concept, extraordinarily complex in execution. The differences between clocks come down to what the algorithm was trained to predict: raw chronological age, biological deterioration, disease risk, or mortality probability.
The First Generation: Horvath’s Pan-Tissue Clock
Steve Horvath published what many consider the foundational epigenetic clock in 2013, and it remains a landmark achievement. Horvath’s clock uses 353 CpG sites measured across multiple tissue types — hence “pan-tissue” — and was trained to predict chronological age with remarkable precision. The mean absolute error was approximately 3.6 years across diverse tissue types, which is genuinely impressive (Horvath, 2013).
What made this clock revolutionary was its universality. Unlike earlier attempts that worked only in specific tissues, Horvath’s algorithm performed across blood, brain, liver, and dozens of other tissue types. This was theoretically exciting and scientifically important. For practical purposes, though, there’s a catch: the clock predicts chronological age very well, but being good at predicting your actual birthday doesn’t tell you much about your health trajectory.
Think of it this way: if I train a model to guess how old someone looks from a photo, and it’s accurate within 3.6 years, that’s impressive pattern recognition. But it doesn’t tell me whether that person will have a heart attack at 55. Accuracy at predicting chronological age is not the same as accuracy at predicting health outcomes. This distinction becomes critical when evaluating which clock you should actually care about.
The Hannum Clock: Blood-Based and Simpler
Around the same time, Hannum and colleagues developed a clock using 71 CpG sites measured specifically in blood. Blood is the tissue you’ll realistically be testing if you use a commercial service, so this matters. The Hannum clock correlates strongly with Horvath’s estimates but diverges in interesting ways, particularly showing more sensitivity to lifestyle factors like smoking and BMI (Hannum et al., 2013).
The practical limitation of both the Horvath and Hannum clocks is that they were designed to track chronological aging. When researchers started asking “does an accelerated epigenetic age predict who dies earlier?” the first-generation clocks showed modest but inconsistent associations with mortality. The field needed something better calibrated to biological deterioration rather than calendar pages.
Second Generation: PhenoAge and the Mortality Dimension
Morgan Levine and colleagues developed PhenoAge, published in 2018, which represents a meaningful leap forward. Instead of training an algorithm purely on chronological age, the researchers first created a composite biological age measure using nine clinical biomarkers — including albumin, creatinine, glucose, C-reactive protein, and others — that are strongly predictive of mortality. They then trained a methylation-based clock to predict this composite phenotypic age rather than chronological age.
The result is a clock that performs better at predicting all-cause mortality, cancer incidence, and health span metrics than its first-generation predecessors. Importantly, PhenoAge acceleration — the gap between your methylation-based biological age and what would be expected — associates with inflammation, immune dysfunction, and metabolic disease in ways the Horvath clock doesn’t capture as cleanly (Levine et al., 2018).
For knowledge workers in their 30s and 40s sitting at desks, stressed, possibly sleep-deprived, and wondering whether their lifestyle habits are actually aging them — PhenoAge gives you more relevant signal than a clock trained to guess your birthday. This is the clock most serious researchers use when studying lifestyle interventions, and that should tell you something.
GrimAge: The Mortality Predictor
If PhenoAge was a step forward, GrimAge felt like a different category entirely when it was published. Developed by Horvath and Lu in 2019, GrimAge was trained not on composite clinical biomarkers but directly on time-to-death and smoking-related plasma proteins. It includes a methylation-based surrogate for pack-years of smoking as one of its components, even for non-smokers, which turns out to capture oxidative stress and inflammation signals more broadly.
GrimAge outperforms all earlier clocks in predicting lifespan, time to cancer diagnosis, coronary heart disease, and physical disability. In multiple independent cohorts, GrimAge acceleration — again, the gap between your biological age estimate and expected — has shown the strongest associations with actual mortality of any DNA methylation clock tested to date (Lu et al., 2019).
This is the clock that makes longevity researchers genuinely excited. It’s also the one most likely to give you information you might find uncomfortable. A GrimAge that runs several years ahead of your chronological age is not a trivial finding — it represents measurable biological wear that independent epidemiological data suggests shortens lifespan. That’s sobering, and it’s also exactly the kind of data that might motivate meaningful behavior change in a way that vague advice about “eating better” never does.
DunedinPACE: Measuring the Speed of Aging
Most clocks give you a snapshot — a single age estimate. DunedinPACE (Pace of Aging Computed from the Epigenome) does something conceptually different and arguably more useful: it measures the rate at which you’re currently aging, calibrated to a longitudinal cohort study from Dunedin, New Zealand that followed the same individuals from birth to midlife.
Because the training data included repeated measurements across time for the same people, DunedinPACE captures dynamic change rather than a static estimate. A score of 1.0 means you’re aging at the average rate. A score of 1.2 means you’re aging 20% faster than average. This framing is intuitive and clinically meaningful in ways that an absolute age number sometimes isn’t.
Early research suggests DunedinPACE is particularly sensitive to interventions — changes in sleep, diet, exercise, and stress management show up in DunedinPACE scores within months rather than years. This makes it potentially the most useful tool for people who want to test whether specific lifestyle changes are actually working at the biological level (Belsky et al., 2022). For a knowledge worker running a self-experiment — cutting alcohol, adding Zone 2 cardio, fixing sleep — DunedinPACE is arguably the most actionable metric available.
Commercial Tests: What You’re Actually Getting
Several companies now offer consumer-facing epigenetic age tests, including TruMe, TruAge (from Elysium Health), Biological Age test from myDNAge, and others. They vary significantly in which clock or combination of clocks they use, sample collection method (dried blood spot versus saliva), laboratory processing quality, and frankly, in how honest they are about the limitations of their algorithms.
Here’s what to look for when evaluating a commercial test:
- Which clock does it use? A product reporting only a Horvath clock-equivalent score is giving you less actionable information than one reporting GrimAge or DunedinPACE. Some tests report multiple clocks, which is actually valuable.
- What’s the sample type? Blood (even dried blood spots) is preferable to saliva for methylation accuracy. Saliva introduces cell-type variability that adds noise.
- How is cell-type composition corrected? Blood is a mixture of immune cells, and the proportions vary between people and across time. Legitimate laboratories correct for this; less rigorous ones don’t, which introduces meaningful error.
- Does the company publish or cite peer-reviewed validation data? Marketing claims are not the same as independent replication.
Pricing ranges from roughly $100 to $500+ per test. Given that meaningful biological changes take months to manifest epigenetically, testing more than twice per year is unlikely to give you interpretable data — so the cost compounds if you’re treating this as a continuous monitoring tool.
What “Accuracy” Actually Means Here
This is where I want to slow down, because the word “accurate” is doing a lot of ambiguous work in this space. Accuracy can mean:
- Technical reproducibility: If you test twice from the same blood sample, do you get the same number? High-quality labs achieve this.
- Correspondence to chronological age: The first-generation clocks excel here. Not necessarily useful for health decisions.
- Predictive validity for health outcomes: This is where GrimAge and PhenoAge outperform earlier clocks, and where the science is most relevant to your actual wellbeing.
- Sensitivity to change: DunedinPACE leads here, making it most useful for tracking interventions.
No single clock is definitively “best” across all four of these dimensions simultaneously. The honest answer is that GrimAge and DunedinPACE are currently the strongest performers for health-relevant prediction and intervention tracking, respectively. If a test offers both — or at least one of them alongside the classic Horvath estimate for context — you’re getting meaningfully better information than a Horvath-only result.
What Actually Moves the Needle on These Clocks?
Knowing your biological age is only useful if you can do something about it. The interventions with the strongest current evidence for slowing or reversing epigenetic age include sustained aerobic exercise, caloric restriction or time-restricted eating, quality sleep (both duration and architecture), smoking cessation (with dramatic effects visible within years), and stress reduction through practices including mindfulness-based interventions.
A landmark clinical trial by Fitzgerald and colleagues demonstrated that a multi-modal intervention combining diet, exercise, sleep, stress management, and specific supplements produced an average 3.23-year reduction in biological age over eight weeks as measured by a methylation clock — a finding that, while it needs replication at scale, suggests epigenetic age is more plastic than many assumed (Fitzgerald et al., 2021).
For knowledge workers specifically — people whose work demands sustained cognitive performance, often under chronic low-grade stress, frequently with disrupted sleep and sedentary days punctuated by intense mental effort — these tools offer something genuinely novel: a way to see whether the habits you think are protecting you are actually registering at the cellular level. The brain doesn’t lie to itself as easily when there’s a number attached to the question.
Practical Guidance for Getting Started
If you want to actually use epigenetic testing intelligently rather than just satisfying curiosity, here’s the thinking framework I’d apply:
- Get a baseline first. Don’t test during a period of unusual stress, illness, or major dietary change. You want a representative snapshot of your current steady state.
- Choose a test that reports GrimAge and/or DunedinPACE. These give you more clinically meaningful information than chronological age predictors alone.
- Pair testing with a specific intervention. Running a self-experiment — changing one or two significant variables and retesting after four to six months — transforms a curiosity exercise into actionable data.
- Don’t treat a single result as destiny. Epigenetic age is modifiable. The whole point of measuring it is to inform change, not to produce anxiety about a fixed fate.
- Consider context. Biological age clocks measure systemic aging patterns but don’t capture everything relevant to health. They’re one layer of information, not the complete picture.
The field is moving fast. Clocks developed just a few years ago are already being superseded by more refined algorithms trained on larger and more diverse cohorts. What’s consistent across the research is that the gap between your biological and chronological age is real, measurable, and influenced by the choices you make day to day. For people who find abstract health advice unconvincing but respond well to concrete data — and if you’re reading a post this detailed, you’re probably in that category — epigenetic testing is one of the more honest windows currently available into how your body is actually doing.
Last updated: 2026-03-31
Your Next Steps
- Today: Pick one idea from this article and try it before bed tonight.
- This week: Track your results for 5 days — even a simple notes app works.
- Next 30 days: Review what worked, drop what didn’t, and build your personal system.
Disclaimer: This article is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about a medical condition.
References
- Apsley AT (2025). From Population Science to the Clinic? Limits of Epigenetic Clocks as Diagnostic Tests. PMC. Link
- Kusters CDJ (2025). Quantification of Epigenetic Aging in Public Health. Annual Review of Public Health. Link
- Horvath S, Raj K (2018). DNA methylation-based biomarkers and the epigenetic clock: applications to the life course of aging. Annual Review of Public Health. Link
- Lu AT, et al. (2019). DNA methylation biomarkers of aging grown old. Aging. Link
- Levine ME, et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging. Link
- McCrory C, et al. (2021). A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration. Ageing Research Reviews. Link
Related Reading
What is the key takeaway about biological age test comparison?
Evidence-based approaches consistently outperform conventional wisdom. Start with the data, not assumptions, and give any strategy at least 30 days before judging results.
How should beginners approach biological age test comparison?
Pick one actionable insight from this guide and implement it today. Small, consistent actions compound faster than ambitious plans that never start.
Get Evidence-Based Insights Weekly
Join readers who get one research-backed article every week on health, investing, and personal growth. No spam, no fluff — just data.